Company
United StatesPublic company, NASDAQ: NKTRNektar Therapeutics (NASDAQ: NKTR), San Francisco, CA – FDA Inspections
Inspection records and compliance data for Nektar Therapeutics in San Francisco, California. 1 FDA inspection on record, last inspected February 01, 2019. Publicly traded as NASDAQ: NKTR.
Company Profile
This profile covers Nektar Therapeutics based in San Francisco, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected February 1, 2019.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 1, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1084539 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Nektar Therapeutics
Stock ticker
NKTR
Exchange
NASDAQ
Share price
$36.43
Market cap
$1.2B
Price as of
November 6, 2026
FEI Number
3008943810
Address
455 Mission Bay Blvd S, San Francisco, California 94158, United States
Country
United States
ID: cd8baf90-666a-405a-88d7-33304d6c3686